TrialReader


The Relationship Between Brain Injury Biomarkers in Cerebrospinal Fluid and Blood of Patients After Cardiac Arrest and Prognosis

NCT06624488 — Recruiting, 30 participants, Tang Ziren

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Relationship Between Brain Injury Biomarkers in Cerebrospinal Fluid and Blood of Patients After Cardiac Arrest and Prognosis.

RegistryNCT06624488
StatusRecruiting
Study typeObservational
Enrollment30 (Estimated)
SponsorTang Ziren (Other)
ConditionsCardiac Arrest (CA), Brain Injuries, Acute
Datesstart 2023-01-01, primary completion 2025-04-01 (estimated), completion 2025-05-01 (estimated), first posted 2024-10-03, last updated 2025-02-21
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cardiac Arrest (CA) All trials for Brain Injuries, Acute

-Summary

This study is a single-center, prospective, observational study. After successful cardiopulmonary resuscitation for patients with cardiac arrest, they will be transferred to the emergency intensive care unit for further standardized targeted temperature management. When evaluating that the patient meets the indications for lumbar puncture and there are no contraindications for lumbar puncture, lumbar puncture examinations will be completed immediately after return of spontaneous circulation (ROSC), at 24 hours of hypothermia, at 72 hours of hypothermia, and after rewarming. Routine cerebrospinal fluid examinations such as cerebrospinal fluid routine, cerebrospinal fluid biochemistry, and cerebrospinal fluid lactate will be sent for inspection. At the same time, 6 ml of cerebrospinal fluid will be retained and stored in a refrigerator at -80°C. After sample collection is completed, enzyme-linked immunosorbent assay (ELISA) will be used to detect markers such as NSE, HCH-L1, NFL, tau, MBP, GFAP, and S100β. While performing the lumbar puncture examination, peripheral blood will be collected. After centrifugation for 10 minutes (4000 revolutions), serum will be retained and stored in a refrigerator at -80°C to complete the examination of the above markers. After 3 months, the patient\'s neurological function prognosis will be followed up according to the Pittsburgh Cerebral Performance Category (CPC) scale.

Expand all sections  ·  Collapse all

+Outcome measures

Primary outcomes

  • Neurologic prognosis [3 months]: Patients will be followed up for neurologic prognosis according to the Pittsburgh Cerebral Performance Category (CPC) scale at 3 months after disease onset.The CPC score ranges from 1 to 5, with 1 indicating good performance, 2 indicating moderate disability, 3 indicating severe disability, 4 indicating vegetative state and 5 indicating brain death or death.

+Eligibility

Sex: All, ages: 18 Years to 80 Years

Inclusion Criteria:

* Age ≥ 18 years old.
* Still lack of directive movements after restoration of spontaneous circulation through cardiopulmonary resuscitation.
* Advanced life support and targeted temperature management are carried out within 6 hours after return of spontaneous circulation (ROSC).

Exclusion Criteria:

* Patients with contraindications for lumbar puncture (severe cerebral edema indicated by brain imaging, disappearance of basal cisterns or occult intracranial mass lesions, receiving antiplatelet and anticoagulant therapy, and those with coagulation disorders).
* Pregnant patients.
* Patients with concomitant traumatic brain injury, stroke, cerebral hemorrhage and other diseases.
* Patients whose families do not agree to be enrolled.

+Locations (1)

FacilityCityCountryStatus
Beijing chaoyang hospitalBeijingChinaRecruiting

My Notes